MedTrace Logo

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

NCT04240444 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2023-11-14

No results posted yet for this study

Summary

This is a prospective, multicenter, randomized controlled clinical trial, which plans to enroll 260 subjects.

Conditions

Interventions

DEVICE

drug-coated balloon Catheter

All eligible subjects will be assigned randomly to study group or control group, receive PTCA.

Sponsors & Collaborators

  • CCRF Inc., Beijing, China

    collaborator INDUSTRY

  • B. Braun Medical International Trading Company Ltd.

    lead INDUSTRY

Principal Investigators

  • Yaling Han, academician · The General Hospital of Northern Theater Command

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-10
Primary Completion
2022-07-26
Completion
2022-08-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04240444 on ClinicalTrials.gov